Oncopeptides AB's market cap is currently kr1.36B. The company's EPS TTM is kr-0.28; its P/E ratio is -4.45; Oncopeptides AB is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
